Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 1
1980 1
1981 1
1982 1
1984 2
1985 3
1986 1
1987 2
1988 3
1989 1
1992 1
1993 1
1994 2
1995 1
1997 1
1998 3
2000 1
2001 1
2002 2
2003 3
2006 3
2007 1
2009 2
2014 1
2015 1
2017 2
2018 4
2020 2
2021 5
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

54 results

Results by year

Filters applied: . Clear all
Page 1
Ultra-early tranexamic acid after subarachnoid haemorrhage (ULTRA): a randomised controlled trial.
Post R, Germans MR, Tjerkstra MA, Vergouwen MDI, Jellema K, Koot RW, Kruyt ND, Willems PWA, Wolfs JFC, de Beer FC, Kieft H, Nanda D, van der Pol B, Roks G, de Beer F, Halkes PHA, Reichman LJA, Brouwers PJAM, van den Berg-Vos RM, Kwa VIH, van der Ree TC, Bronner I, van de Vlekkert J, Bienfait HP, Boogaarts HD, Klijn CJM, van den Berg R, Coert BA, Horn J, Majoie CBLM, Rinkel GJE, Roos YBWEM, Vandertop WP, Verbaan D; ULTRA Investigators. Post R, et al. Among authors: bienfait hp. Lancet. 2021 Jan 9;397(10269):112-118. doi: 10.1016/S0140-6736(20)32518-6. Epub 2020 Dec 23. Lancet. 2021. PMID: 33357465 Clinical Trial.
Second intravenous immunoglobulin dose in patients with Guillain-Barré syndrome with poor prognosis (SID-GBS): a double-blind, randomised, placebo-controlled trial.
Walgaard C, Jacobs BC, Lingsma HF, Steyerberg EW, van den Berg B, Doets AY, Leonhard SE, Verboon C, Huizinga R, Drenthen J, Arends S, Budde IK, Kleyweg RP, Kuitwaard K, van der Meulen MFG, Samijn JPA, Vermeij FH, Kuks JBM, van Dijk GW, Wirtz PW, Eftimov F, van der Kooi AJ, Garssen MPJ, Gijsbers CJ, de Rijk MC, Visser LH, Blom RJ, Linssen WHJP, van der Kooi EL, Verschuuren JJGM, van Koningsveld R, Dieks RJG, Gilhuis HJ, Jellema K, van der Ree TC, Bienfait HME, Faber CG, Lovenich H, van Engelen BGM, Groen RJ, Merkies ISJ, van Oosten BW, van der Pol WL, van der Meulen WDM, Badrising UA, Stevens M, Breukelman AJ, Zwetsloot CP, van der Graaff MM, Wohlgemuth M, Hughes RAC, Cornblath DR, van Doorn PA; Dutch GBS Study Group. Walgaard C, et al. Among authors: bienfait hme. Lancet Neurol. 2021 Apr;20(4):275-283. doi: 10.1016/S1474-4422(20)30494-4. Epub 2021 Mar 17. Lancet Neurol. 2021. PMID: 33743237 Clinical Trial.
No Laughing Matter: Burning Feet.
Bode SA, Bienfait HP, Adriaansen HJ, van Suijlen JDE. Bode SA, et al. Among authors: bienfait hp. J Appl Lab Med. 2021 Jul 7;6(4):1067-1071. doi: 10.1093/jalm/jfaa220. J Appl Lab Med. 2021. PMID: 33444452 Free article. No abstract available.
Wake-Up Stroke versus Stroke with Known Onset Time: Clinical and Multimodality CT Imaging Characteristics.
Dankbaar JW, Bienfait HP, van den Berg C, Bennink E, Horsch AD, van Seeters T, van der Schaaf IC, Kappelle LJ, Velthuis BK; on behalf of the DUST investigators. Dankbaar JW, et al. Among authors: bienfait hp. Cerebrovasc Dis. 2018;45(5-6):236-244. doi: 10.1159/000489566. Epub 2018 May 17. Cerebrovasc Dis. 2018. PMID: 29772576 Free PMC article.
Tranexamic Acid After Aneurysmal Subarachnoid Hemorrhage: Post Hoc Analysis of the ULTRA Trial.
Tjerkstra MA, Post R, Germans MR, Vergouwen MDI, Jellema K, Koot RW, Kruyt ND, Willems PWA, Wolfs JFC, de Beer FC, Kieft H, Nanda D, van der Pol B, Roks G, de Beer F, Halkes PHA, Reichman LJA, Brouwers PJAM, Van den Berg-Vos RM, Kwa VIH, van der Ree TC, Bronner I, Bienfait HP, Boogaarts H, Klijn CJM, van den Berg R, Coert BA, Horn J, Majoie CBLM, Rinkel GJE, Roos YBWM, Vandertop WP, Verbaan D; ULTRA investigators. Tjerkstra MA, et al. Among authors: bienfait hp. Neurology. 2022 Dec 5;99(23):e2605-e2614. doi: 10.1212/WNL.0000000000201160. Neurology. 2022. PMID: 36266046 Clinical Trial.
Changing incidence and improved survival of gliomas.
Ho VK, Reijneveld JC, Enting RH, Bienfait HP, Robe P, Baumert BG, Visser O; Dutch Society for Neuro-Oncology (LWNO). Ho VK, et al. Among authors: bienfait hp. Eur J Cancer. 2014 Sep;50(13):2309-18. doi: 10.1016/j.ejca.2014.05.019. Epub 2014 Jun 24. Eur J Cancer. 2014. PMID: 24972545
[Addendum to the Dutch guideline for minor head/brain injury].
van den Brand CL, van der Naalt J, Hageman G, Bienfait HP, van der Kruijk RA, Jellema K. van den Brand CL, et al. Among authors: bienfait hp. Ned Tijdschr Geneeskd. 2017;161:D2258. Ned Tijdschr Geneeskd. 2017. PMID: 29241468 Dutch.
54 results